Generally, MAPKi-persistent [75,76,82] and -resistant melanomas are more invasive [53,83,84] and, with increased lung colonization ability [53], which is indicative of enhanced metastatic potential, providing further evidence of the involvement of RHO GTPase signalling and the actomyosin cytoskeleton in therapy resistance. Here, RHO is linked to melanoma.